Moving towards individualized target-based therapies in acute myeloid leukemia. Bazinet A, Kantarjian HM. Ann Oncol 2022 Nov 21:S0923-7534(22)04734-2. doi: 10.1016/j.annonc.2022.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bazinet A, Kantarjian HM. Moving towards individualized target-based therapies in acute myeloid leukemia. Ann Oncol 2022 Nov 21:S0923-7534(22)04734-2. doi: 10.1016/j.annonc.2022.
PMID: 36423744